Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Indiana University
With
Pfizer
University of Pennsylvania
University of South Florida
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects will include men and women over the age of eighteen;
the ability to give written informed consent;
current principal or co-principal psychiatric diagnosis of panic disorder with or without agoraphobia based on DSM-IV criteria (American Psychiatric Association, 1994);
willing to use an effective means of contraception;
free of psychoactive medications for at least 2 weeks prior to study enrollment;
not actively be suicidal.
You may not be if
actively suicidal;
medical conditions for which either sertraline or alprazolam XR would be contraindicated;
recent six month history of substance or alcohol abuse;
history or presence of psychotic or bipolar disorder;
women who are pregnant or breastfeeding;
history or presence of a seizure disorder or a known history of more than one childhood febrile seizure;
presence of a personality disorder severe enough to compromise the investigator's ability to evaluate the efficacy and safety of the study medication;
concomitant therapy with other psychotropic medication(s);
clinically significant abnormality during physical examination, vital signs, EKG, urine drug screen, or laboratory tests at the screen visit.
Clareo Health | A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients
